Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Current Assets (2016 - 2025)

Historic Current Assets for Dr Reddys Laboratories (RDY) over the last 14 years, with Q3 2025 value amounting to $3.2 billion.

  • Dr Reddys Laboratories' Current Assets rose 814.54% to $3.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.2 billion, marking a year-over-year increase of 814.54%. This contributed to the annual value of $2.9 billion for FY2025, which is 161.29% down from last year.
  • According to the latest figures from Q3 2025, Dr Reddys Laboratories' Current Assets is $3.2 billion, which was up 814.54% from $2.9 billion recorded in Q1 2025.
  • Dr Reddys Laboratories' Current Assets' 5-year high stood at $3.2 billion during Q3 2025, with a 5-year trough of $2.0 billion in Q1 2021.
  • Moreover, its 5-year median value for Current Assets was $2.6 billion (2023), whereas its average is $2.6 billion.
  • Per our database at Business Quant, Dr Reddys Laboratories' Current Assets skyrocketed by 2156.21% in 2021 and then tumbled by 330.08% in 2025.
  • Dr Reddys Laboratories' Current Assets (Quarter) stood at $2.2 billion in 2021, then fell by 0.04% to $2.2 billion in 2022, then rose by 19.56% to $2.6 billion in 2023, then grew by 12.49% to $3.0 billion in 2024, then grew by 8.15% to $3.2 billion in 2025.
  • Its last three reported values are $3.2 billion in Q3 2025, $2.9 billion for Q1 2025, and $3.0 billion during Q3 2024.